摘要
目的：
本课题旨在观察子午流注法治疗脾虚湿盛型单纯性肥胖症的临床疗效,为进一步推广提供临床依据。
方法：
研究对象为在台湾赖郁凯中医诊所治疗的符合病例筛选标准的60例脾虚湿盛型单纯性肥胖症患者。按照进入实验的编号随机分为子午流注法治疗组(简称治疗组)与对照组,治疗组按照子午流注时辰原则,脾虚湿盛型单纯性肥胖症患者在巳时(北京时间9点-11点)选取脾经五输穴,即隐白、大都、太白、商丘、阴陵泉穴位进行针刺；对照组则不在巳时进行针刺(除了巳时的任何时间),针刺穴位仍然为脾经五输穴。两组患者在一周治疗5次,四周为一疗程,连续治疗两个疗程。每个疗程后选用体重指数(BMI)、体重指数BMI评价疗效、腰臀比(WHR)、脾虚湿盛型中医症候评分、血高密度脂蛋白胆固醇(HDL-C)、血低密度脂蛋白胆固醇(LDL-C)血总胆固醇(TC)及血甘油三酯(TG)等指标进行评价。将数据记录输入SPSS18.0进行统计分析,
结果：
两组入选的病例在年龄均数及分布情况、体重指数、肥胖程度、腰臀比、中医症候评分、血脂四项等方面都没有显著性差异(P>0.05),具有可比性。1.治疗组在利用子午流注治疗4周后,BMI显著下降(P<0.05),8周后下降更明显(P<0.01),对照组治疗4周后,BMI与治疗前比较下降不明显(P>0.05),但是8周后,有显著下降(P<0.05)。组间比较显示：4周后,两组无明显区别(P>0.05),8周后,治疗组在降低BMI方面优于对照组(P<0.05)。
2.利用子午流注治疗4周后,治疗组与对照组的WHR都没有显著性变化(p>0.05),在8周后,WHR有明显改善(P<0.05)。说明WHR的改变需要更长时间的巩固。两组组间比较提示：4周后,两组对于改善WHR没有明显差异(P>0.05),但是8周后,治疗组优于对照组(P<0.05)。
3.利用子午流注治疗4周后,治疗组与对照组的中医证候疗效评分都有显著性降低(P<0.05),说明对于脾虚湿盛的症状有所改善,并且在8周后,改善更明显(P<0.01)。两组组间比较提示：4周后,两组对于改善脾虚湿盛的症状没有明显差异(P>0.05),但是8周后,治疗组优于对照组(P<0.05)。
4.利用子午流注治疗4周后,治疗组与对照组的血高密度脂蛋白胆固醇(HDL-C)、血低密度脂蛋白胆固醇(LDL-C)及血总胆固醇(TC)都没有显著性变化,在8周后,血甘油三酯(TG)有明显降低。两组组间比较提示：4周后,两组对于血脂四项没有明显差异,但是8周后,针对TG治疗组优于对照组。
结论：
利用子午流注法治疗脾虚湿盛型单纯性肥胖症能显著降低BMI及WHR,改善脾虚湿盛的症状情况及改善TG情况,并且如果按照子午流注时辰原则施以针刺,则疗效更显著。
Objective:
This research attempts to study the clinical curative effect of Midnight-moon and Ebb-flow Doctrine in the treatment of Simple Obesity of the type of Damp Abundance due to Splenic Asthenia and provide clinical proof for its further promotion.
Methods:
Select60patients who meet the case selection criteria of Simple Obesity in the type of Damp Abundance due to Splenic Asthenia from Dr. Lai Yukai's TCM Clinic in Taiwan as research objects. Randomly classify the objects into the Midnight-moon and Ebb-flow Doctrine Group (Treatment Group) and the Control Group according to the serial number of joining the research. Based on the Hour Principle of Midnight-moon and Ebb-flow Doctrine, patients of Simple Obesity in the type of Damp Abundance due to Splenic Asthenia in the Treatment Group were given acupuncture treatment on the five Shu-acupoints on the spleen meridian, i.e. Yinbai, Dadu, Taibai, Shangqiu, Yinlingquan at the hour of the sixth of the twelve Earthly Branches (9to11a.m. of Beijing Time). Acupuncture is given to patients in the Control Group on the same five Shu-acupoints on the spleen meridian at other time except9to11a.m. of Beijing Time. Patients in the two groups are treated5times a week for two consecutive treatment courses with4weeks as one treatment course. After each course, evaluate such indexes as TCM Syndrome Scoring for Damp Abundance due to Splenic Asthenia, BMI, BMI-related Curative Effect Evaluation, HDL-C, LDL-C, TC, TG, etc. Input and analyze these data by SPSS18.0Software.
Results:
No significant difference is found among the cases of the two groups in aspects of age average and its distribution, BMI, obesity degree, TCM Syndrome Scoring and blood lipid (HDL-C, LDL-C, TC, TG) which demonstrates comparability (P>0.05)
1. Patients'BMI in the Treatment Group decreases significantly after4weeks of treatment with Midnight-moon and Ebb-flow Doctrine (P<0.05), and it decreases more obviously after8weeks (P<0.01). Patients'BMI in the Control Group doesn't decrease obviously after4weeks of treatment with Midnight-moon and Ebb-flow Doctrine (P>0.05) compared with that before treatment, but it decreases significantly after8weeks (P<0.05). The intergroup comparison demonstrates that no obvious difference is found between the two groups after4weeks (P>0.05), while after8weeks, the Treatment Group is superior to the Control Group in lowering BMI (P<0.05)
2. No significant change is found in WHR of two groups after4weeks' treatment with Midnight-moon and Ebb-flow Doctrine (P>0.05), while obvious improvement is observed after8weeks (P<0.05). The intergroup comparison indicates that after4weeks, there's no obvious difference between two groups in improving the WHR, but after8weeks, the Treatment Group is superior to the Control Group (P<0.05)
3. The TCM Syndrome Scores are significantly lowered in the Treatment Group and the Control Group after4weeks'treatment with Midnight-moon and Ebb-flow Doctrine(P<0.05) which explains that symptoms of Damp Abundance due to Splenic Asthenia are improved at certain degree. The improvements are more obvious after8weeks (P<0.01). The intergroup comparison demonstrates that no obvious difference is found between the two groups after4weeks in improving symptoms of Damp Abundance due to Splenic Asthenia (P>0.05), while after8weeks, the Treatment Group is superior to the Control Group (P<0.05)
4. No significant change is found in blood lipid HDL-C, LDL-C, TC and TG of two groups after4weeks'treatment with Midnight-moon and Ebb-flow Doctrine (P>0.05), while obvious improvement of TG is observed after8weeks (P<0.05). The intergroup comparison indicates that after4weeks, there's no obvious difference between two groups in improving the blood lipid HDL-C, LDL-C, TC and TG (P>0.05), but after8weeks, the Treatment Group of TG is superior to the Control Group (P<0.05)
Conclusion:
Applying Midnight-moon and Ebb-flow Doctrine in the treatment of Simple Obesity in the type of Damp Abundance due to Splenic Asthenia can significantly lower BMI, improve the symptoms of damp abundance and splenic asthenia and lower high blood lipid. Combining with the acupuncture treatment according to the Midnight-moon and Ebb-flow Hour Principle, the curative effect will be more obvious.
引文
[1]李松,邹旭,邓铁涛.肥胖机制及中医药防治肥胖症的研究进展[J].中西医结合心脑血管病杂志,2004,2(11)：658.
[2]陈艳,龚婕宁,徐小萍.中药治疗肥胖的研究进展[J].辽宁中医要大学学报,2011,13(11)：266.
[3]谢海洲.皂荚驱痰通关减肥[J].中医杂志,1995,36(12)：753
[4]景虎修.单用枸杞子治疗肥胖病[J].安阳医刊,1989,5(1)：34-35
[5]郑毅男,刘可越,徐宝军,等.桔梗抗肥胖机理研究[J].吉林农业大学学报,2002,24(6)：42
[6]阎君宝,金龙,汪江碧,等.决明子抑制营养性肥胖大鼠体重增加的作用[J].中药材,27(4)：281
[7]宁安红,黄敏,戴兵,等.灵芝菌丝发酵提取液减肥作用的初步探讨[J].中国微生物学杂志,2004,16(2)：77-79
[8]高雅萍,焦东海,王梅莉.大黄提取片对单纯性肥胖大鼠高胰岛素血症的作用[J].中国实验方剂学杂志,2002,8(6)：29.
[9]田雪松,闫君宝,罗蓉,等.绵马贯众对去卵巢肥胖大鼠的影响[J].陕西中医,2004,25(5)：417
[10]宰军华,李桓,杜非洲.“治未病”理论在防治单纯性肥胖病及其并发症中的运用[J].河南中医学院学报,2009,1(24)：18-19.
[11]李萍,佟晓华,李玉林.小儿复方减肥冲剂对小鼠体重和血脂的影响[J].中国实验动物学杂志,1998,8(3)：139
[12]郭盛,何丽,刘昌玉.活血化瘀法对营养型肥胖大鼠胰岛素敏感指数及脂肪组织中肿瘤坏死因子-a的影响[J].现代中西医结合杂志,2004,13(16)：21-27.
[13]张忠亮,傅乐之.推拿气功中药治疗的减肥效果[J].按摩与导引,1995(5)：21-22
[14]史大永,李良智,李旭云.中药减肥的处方研究[J].青岛化工学院学报.2001,22(2)：161-162.
[15]王玉芬.妇女单纯性肥胖病的中医治疗[J].中国农村医学,1987,5(10)：59-60
[16]郭义然.罗四维治疗肥胖症经验[J].江苏中医,2000,31(2)：6
[17]金小琴,宰军华.从脏腑学说论肥胖症的病机与治疗[J].中国民族民间医药,2010,16(34)：7-8.
[18]章海风.中医药膳减肥的研究现状[J].扬州大学烹饪学报,2006,4(23)：4.
[19]周楹.肥胖病的辨证治疗[J].职业与健康,2003,19(6)：105.
[20]崔鸿峥.针灸治疗单纯性肥胖症246例[J].中国临床康复,2005,9(11)：185.
[21]李嘉,刘志诚.针刺治疗单纯性肥胖病40例疗效观察[J].中国针灸,1998,18(9)：539.
[22]赵辉,张宁苏,杨德治.针刺治疗单纯性肥胖126例分析[J].实用中医内科杂志,2003,17(2)：143.
[23]汪慧敏.腹八针为主减肥35例[J].实用中医药杂志,2003,19(7)：371.
[24]施茵,张琳珊,赵琛,等.温针灸和电针治疗脾虚型单纯性肥胖症的对照研究[J].中国针灸,2005,25(7)：465-467
[25]孟丽娟,孟宪鹏,高秀丽.电针辩证治疗女性单纯性肥胖180例[J].中国临床康复,2002,23(6)：35-36.
[26]李毅.针刺治疗单纯性肥胖症48例[J].中国针灸,2002,22(增刊)：62.
[27]赵锦梅,高亚伟.耳穴贴压减肥70例疗效观察[J].陕西中医学院学报,1996,19(3)：38-39.
[28]刘运珠.针刺为主治疗单纯性肥胖疗效观察[J].中国针灸,2002,22(2)：93-94
[29]齐风军,程井军.穴位埋线减肥60例临床观察[J].针灸临床杂志,2006,22(7)：34
[30]聂莉.穴位埋线法治疗单纯性肥胖症[J].中国美容医学,2007,16(2)：255、257
[31]刘远珍,徐琳兰.穴位埋线治疗单纯性肥胖症疗效观察[J].中医护理,2007,22(17)：34-35
[32]李雪莹,葛宝和.穴位埋线疗法治疗肥胖症的临床研究[J].中国中医药科技,2006,13(2)：70-72
[33]熊健,左珊珊.穴位埋线治疗单纯性肥胖25例临床观察[J].中医药导报,2006,12(9)：34-35
[34]曹春,王飞.穴位埋藏法治疗单纯性肥胖[J].中国自然医学杂志,2002,4(3)：178-179.
[35]庞爱军,吴文华.穴位埋入中药浸泡羊肠线治疗单纯性肥胖症150例疗效分析[J].中外健康文摘,2007,4(1)：34-35
[36]姜兴鹏,陈春梅,陈伟薄氏腹穴药线植入消脂减肥法临床应用50例[J].中国民间疗法,2005,13(6)：13
[37]刘宁,王琳.穴位埋线结合中胚层疗法治疗单纯性肥胖[J].中国美容整形外科杂志,2007,18(3)：163-165
[38]曾炳昌.穴位埋药线合并中药治疗单纯性肥胖症的临床研究[D].中国博士学位论文全文数据库,2008
[39]龙志江,章薇.穴位埋线加耳压疗法治疗单纯性肥胖症68例总结[J].湖南中医杂志,2004,20(3)：6-7
[40]刘玲玲,李智红.针刺加穴位埋线治疗青年单纯性肥胖症临床观察[J].上海针灸杂志,2008,27(10)：7-8
[41]马丹.穴位埋线为主治疗单纯性肥胖症100例[J].国际中医中药杂志,2007,29(3)：182-183
[42]宓轶群.针刺治疗单纯性肥胖症80例临床观察[J].中国针灸,2005,25(2)：95-96.
[43]任晓艳.穴位埋线的源流及其机理探讨[J].中国医药学报,2004,19(12)：757-759
[44]杨水凤,王延武.埋线疗法对肥胖大鼠大脑纹状体NO和NOS含量的影响[J].浙江中医杂,2008,43(7)：380-381
[45]王澍欣,李艳慧.穴位埋线对肥胖模型大鼠瘦素水平及血脂的影响[J].天津中医药,2009,28(01)：63-65
[46]刘卫英,邓元江,彭楚湘,等穴位埋线抗青霉素致痫大鼠癫痫发作的行为学观察[J].中国中医药信息杂志,2006,13(4)：18-20
[47]姜美香,刘翠芳,李梅香.针推治疗肥胖症的临床观察[J].按摩与导引,2003,19(1)：17-18.
[48]杜兆友.针刺配合推拿法为主治疗肥胖病200例[J].山西中医,2007,23(4)：56-57.
[49]唐红珍,夏猛.中医综合减肥法对肥胖症大鼠血清瘦素的影响[J].辽宁中医杂志,2010,37(2)：365.
[50]黄龙坚.中医综合疗法治疗单纯性肥胖的疗效观察[J].广西中医药,2009,32(5)：12.
[51]孔凡涵,孔琳.刍议中医对肥胖的认识及早期辨治干预的意义[J].中国中医药现代远程教育,2010,8(21)：7.
[52]孙志娟,黄之瑜.肥胖的研究进展[J].生理科学通报,2001,32(1)：39-44
[53]Considine RV, Sinha MK, Heiman ML, et al. Serumim-munoreactive-leptin concentrations in normal weight andobese humans[J].N Engl J Med,1996,334:292-295
[54]刘荣.肥胖抵抗现象的研究概况[J].国外医学卫生学分册,2002,29(3)：153-156
[55]Byyny RL, Loverde M, Lioyd S, et al. Cytosolic calcium and insulin resistance in elderly patients with essential hyper-tension[J]. Am J Hypertension,1992,5:459-464
[56]Durandar NV, Kulkarni PR, Ajinkya SM, et al. Screening of human sera for antibody against avain adenovirus[J]. ObesRes,2004,5(5):464-469.
[57]Atkinson RL, Dhurandhar NV, Allison DB, et al. Evidence for an association of an obesity virus with human obesity at three site in the united states[J]. Int J Obes, 2005,22(1):57-61.
[58]Ning G. Coordination Group of Pos-tMarketing Evaluationof Qumei. A multicenter and open study on efficacy and safety of sibutramine in obesesubjects[J]. Zhonghua Yi Xue Za Zhi,2004,84(15):1243-1246.
[59]Nulty SJ, Ur E, Williams G. A randomized trial of sibutramine in the management of obese type2 diabetic patients treated with metformin[J]. DiabetesCare,2003,26(1): 125-131.
[60]文重远.西布曲明对单纯性肥胖减重的疗效观察[J]1临床内科杂志,2002,19(3)：219-220
[61]Davidson MH, Hauptman J, DiGirolamo M. Weight control and risk factor sreductioninobese subject streated for 2years with orlistat [J]. JAMA,1999,281(3):235-242.
[62]Sjostrom L, Rissanen A, Adersen T, et al. Ran-domisedplacebo-controlledtrial of orlistat for weight loss and prevention of weight regain in obese patients[J]. Lancet,1998,352(9123):167-173.
[63]Rssner S, SjstrmL, Noack R, et al. Weight loss, weight mainte-nance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Eur Opean Orlistat ObesityStudy Gruop[J]. ObesRes,2000,8(1):49-61.
[64]Ballinger A. Orlistat in the treatment of obesity [J]. Expert OpinPhar-macother,2000, 1(4):841-847.
[65]Schneider BE, MunEClSurgical management of morbidobe-sity[J]. Diabetes Care,2005, 28(2):475-4801
[66]郑成竹.中国肥胖病外科治疗指南(2007)[J].中国实用外科杂志,2007,27(10)：759-762
[67]Mason EE. Vertical banded gastropalsty for morbid obesity[J]. Arch Surg,1982,117(5): 701-706.
[68]FlumDR, Dellinger E P1Impact of gastricbypass operation on survival:a population-based analysis[J]. J AmColl Surg,2004,199(4):543-5511
[69]Hsu LK, BenottiPN, Dwyer J, et al. Nonsurgical factors that influence the outcome of bariatric surgery:Areview[J]. Psy-chosomMed,1998,60(3):338-3461
[70]MorsyMA, GuM, MotzelS, et al. Anadenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expressionof aleptintransgene[J]. ProcNatlAcad SciUSA,1998,95:7866-7871
[71]Morsy MA, Gu MC, Zhao JZ, et al. Leptin gene therapy and dailyprotein administration: a comparative study in the ob/ob mouse[J]. GeneTher,1998,5:8-18.
[72]Chen G, Koyama K, Yuan X, et al. Disappearance of body fatin normal rats induced by adenovirus-mediated leptin gene therapy[J]. ProcNatl Acad Sci USA,1996,93: 14795-4799
[73]管遵惠,易荣,叶建,等.子午流注开穴对中风病人心肌缺血影响的研究[J].中国针灸,2005,25(11)：823-824
[74]姜华,王满侠,郭健,等.子午流注纳甲法治疗急性缺血性脑中风及对血液流变学的影响[J].中国中医药信息杂志,2003,10(5)：75-76.
[75]谭保华,徐杰,管遵惠.子午流注针法治疗中风病220例临床研究[J].云南中医中药杂志,1999,20(1)：5-7.
[76]赵天平,仇裕丰.养子时刻开穴法治疗原发性痛经27例[J].浙江中医杂志,2000,35(8)：351.
[77]沙玉芹,黄泳子午流注纳甲法纳子法对中风病人脂蛋白载脂蛋白影响的比较研究[J].中国中医药科技,1997,4(6)：338.
[78]燕平,王维峰子午流注取穴法对家兔白细胞数的影响[J].中医药研究,1995,15(1)：36.
[79]宋开源.不同时辰针刺大白鼠涌泉穴对痛阈和脑内单胺类介质的影响[J].子午流注针法原理研究.云南中医杂志,1986,7(4)：1.
[80]李磊,陈汉平,奚永江等.不同时辰针灸不同穴位对荷瘤小鼠生化和免疫功能的影响[J].津中医学院学报,1994,13(4)：24
[81]周丽莎,涂乾.子午流注纳支法对大鼠醋酸性胃溃疡愈合影响的实验研究[J].中医药研究,2001,17(4)43-45
[82]管遵惠,金建华,申晓月.子午流注灸法治疗高脂血症50例临床观察[J].中医杂志,1994,2：108
[83]吴静,吴兆苏,张瑞按.体重指数、腰围/臀围比与血压、血脂的相关性.心肺血管病杂志.1995,14(4)：214-217
[84]Goran MI. Metabolic precursors and effects of obesity in children:a decade progress.1990-1999[J]. Am. J. Clin. Nutr.,2001,73:158-171
[85]王兆禹,卫明英.肥胖与心血管系统[J].心血管病学进展,1996,17：40.
[86]潘玥,何泳,王永刚等.青少年肥胖相关指标探讨.中国卫生检验杂志,2011,21(6)：1477-1478
[87]黄晓丽,李可兴,张文英.湖南省肥胖中学生身体形态指标与血脂水平的相关性研究.商丘师范学院学报,25(12)：125-129
[88]范晓晨,都鹏飞,金咏梅.单纯性肥胖儿童血脂脂蛋白的变化及相关因素分析.安徽医学,2009.30(3)：222-225
[89]李林中,胡小琪,崔朝辉等.北京市城区9-10岁儿童肥胖相关指标与血脂水平关系的探讨.中华流行病学杂志,2007,28(8)：734-737
[90]王维敏,朱大龙,朱妍等.肥胖程度对血脂等相关代谢因素的影响.中国糖尿病杂志,2008.16(1)：4-6
[91]叶任高.内科学[M].第5版.北京：人民卫生出版社,2000.843
[92]尹汤恒.肥胖症的血脂、血糖、血压及相关因素分析.华夏医学：16(4)：476-478
[93]杨文英,邢小燕.肥胖和代谢综合症[J]新医学,2002,33(4)：197